- HIGH
- Research
- Tier 1
- Hard News
Oral Cancer in America
- Source
- CareQuest Institute
- Author
- Lisa Sall
- Originally at
- carequest.org(opens in a new tab)
Summary and scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol. Not the original publisher.
Why it matters for dental
CareQuest Institute's latest claims analysis shows oral-cancer incidence remains higher among Medicaid enrollees than commercially insured patients, giving dental teams treating those populations a clearer signal for targeted screening.
Key points
- 01
CareQuest Institute compared 2019–2022 medical and dental claims data for oral-cancer incidence, prevalence, and cost.
- 02
Medicaid incidence declined from 67.1 to 49.0 cases per 100,000 enrollees, while commercial rates stayed flat.
- 03
Oral-cancer treatment costs were higher for commercial insurance than for Medicaid across the study period.
- 04
The report notes HPV accounts for 60–70 % of cases and states the HPV vaccine has been found to lower risk.
Who should care
- Owner
- Associate
- Staff
- Academia / research
Read the original
CareQuest Institute
Full reporting and any paywalled content live on carequest.org. We summarize and score; we do not republish.